TrialHead & neck2016

Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.

Matthew G Fury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.